Physician profile
Andreas M Staebler
NPI 1568624021
$708.92
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $196 · 2021: $166 · 2022: $12.39.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $298.84 | 2019-2021 | |
| Novo Nordisk INC | $54.03 | 2019-2020 | |
| Therapeuticsmd, INC. | $53.65 | 2019-2020 | |
| Avion Pharmaceuticals | $47.94 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.77 | 2019-2020 | |
| Pfizer INC. | $36.19 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $29.29 | 2019 | |
| Exeltis, USA INC. | $27.54 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $24.95 | 2019-2020 | |
| Coopersurgical, INC. | $24.14 | 2019 | |
| Hologic Sales and Service, LLC | $19.11 | 2019 | |
| Daiichi Sankyo INC. | $16.25 | 2020 | |
| Alexion Pharmaceuticals, INC. | $13.35 | 2020 | |
| Sage Therapeutics, LLC | $12.39 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.48 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andreas Staebler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.